Pure Financial Advisors LLC Has $405,000 Stock Holdings in Corteva, Inc. $CTVA

Pure Financial Advisors LLC raised its stake in shares of Corteva, Inc. (NYSE:CTVA) by 7.9% during the 2nd quarter, HoldingsChannel reports. The firm owned 5,438 shares of the company’s stock after purchasing an additional 397 shares during the quarter. Pure Financial Advisors LLC’s holdings in Corteva were worth $405,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in CTVA. Nuveen LLC acquired a new position in Corteva during the first quarter valued at approximately $640,333,000. Assenagon Asset Management S.A. grew its stake in shares of Corteva by 4,769.2% in the second quarter. Assenagon Asset Management S.A. now owns 1,924,419 shares of the company’s stock worth $143,427,000 after acquiring an additional 1,884,897 shares during the last quarter. JPMorgan Chase & Co. grew its stake in shares of Corteva by 54.6% in the first quarter. JPMorgan Chase & Co. now owns 5,009,038 shares of the company’s stock worth $315,219,000 after acquiring an additional 1,769,355 shares during the last quarter. Price T Rowe Associates Inc. MD grew its stake in shares of Corteva by 65.8% in the first quarter. Price T Rowe Associates Inc. MD now owns 3,251,449 shares of the company’s stock worth $204,615,000 after acquiring an additional 1,290,009 shares during the last quarter. Finally, Vanguard Group Inc. grew its stake in shares of Corteva by 0.8% in the first quarter. Vanguard Group Inc. now owns 79,814,646 shares of the company’s stock worth $5,022,736,000 after acquiring an additional 639,799 shares during the last quarter. Institutional investors and hedge funds own 81.54% of the company’s stock.

Insider Activity at Corteva

In other news, EVP Robert D. King sold 37,280 shares of the business’s stock in a transaction on Friday, August 29th. The shares were sold at an average price of $74.20, for a total value of $2,766,176.00. Following the sale, the executive vice president owned 49,262 shares in the company, valued at approximately $3,655,240.40. The trade was a 43.08% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Corporate insiders own 0.14% of the company’s stock.

Corteva Stock Down 0.2%

CTVA opened at $63.36 on Friday. Corteva, Inc. has a fifty-two week low of $53.40 and a fifty-two week high of $77.41. The company has a debt-to-equity ratio of 0.06, a current ratio of 1.68 and a quick ratio of 1.23. The firm’s fifty day moving average price is $71.24 and its two-hundred day moving average price is $68.85. The company has a market capitalization of $43.03 billion, a P/E ratio of 30.91, a P/E/G ratio of 1.43 and a beta of 0.76.

Corteva (NYSE:CTVA) last posted its quarterly earnings results on Wednesday, August 6th. The company reported $2.20 earnings per share for the quarter, topping analysts’ consensus estimates of $1.89 by $0.31. Corteva had a net margin of 8.16% and a return on equity of 8.68%. The firm had revenue of $6.46 billion for the quarter, compared to the consensus estimate of $6.26 billion. During the same quarter in the previous year, the company earned $1.83 earnings per share. The business’s revenue was up 5.6% compared to the same quarter last year. On average, analysts anticipate that Corteva, Inc. will post 2.96 EPS for the current year.

Corteva Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Monday, September 15th. Stockholders of record on Tuesday, September 2nd were paid a $0.18 dividend. The ex-dividend date was Tuesday, September 2nd. This represents a $0.72 annualized dividend and a dividend yield of 1.1%. This is a boost from Corteva’s previous quarterly dividend of $0.17. Corteva’s dividend payout ratio is presently 35.12%.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently issued reports on CTVA shares. Zacks Research upgraded shares of Corteva from a “hold” rating to a “strong-buy” rating in a research note on Wednesday. Royal Bank Of Canada restated an “outperform” rating on shares of Corteva in a research note on Monday, August 11th. Morgan Stanley set a $84.00 price objective on shares of Corteva in a research note on Monday, September 15th. Wall Street Zen upgraded shares of Corteva from a “hold” rating to a “buy” rating in a research note on Saturday, August 9th. Finally, Barclays upgraded shares of Corteva from an “equal weight” rating to an “overweight” rating and raised their price objective for the stock from $75.00 to $84.00 in a research note on Wednesday, August 13th. One research analyst has rated the stock with a Strong Buy rating, fourteen have issued a Buy rating and three have assigned a Hold rating to the company. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus price target of $80.67.

Corteva Company Profile

Corteva, Inc operates in the agriculture business. It operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics.